Elevance Health Inc. (ELV) Revenue CAGR:9.45%(TTM)
The revenue cagr for Elevance Health Inc. (ELV) is +9.45% over the latest trailing 12-month period. Revenue CAGR uses precomputed financial statement history.
The revenue cagr for Elevance Health Inc. (ELV) stock is 9.45% over the past 12 months. The 3 year average growth rate is 7.64% and the 5 year cagr is 9.97%. Revenue CAGR measures how Elevance Health Inc.'s top-line revenue has grown over time. Consistent revenue growth is a key indicator of business expansion and market share gains.
ELV Revenue CAGR Chart
Elevance Health Inc. (ELV)
ELV Revenue CAGR History
| Year | Start Revenue | End Revenue | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2025 | $176.81B | $199.13B | +$22.32B | +12.62% | +12.62% |
| 2024 | $171.34B | $176.81B | +$5.47B | +3.19% | +3.19% |
| 2023 | $156.59B | $171.34B | +$14.74B | +9.42% | +9.42% |
| 2022 | $138.64B | $156.59B | +$17.96B | +12.95% | +12.95% |
| 2021 | $121.87B | $138.64B | +$16.77B | +13.76% | +13.76% |
| 2020 | $104.21B | $121.87B | +$17.65B | +16.94% | +16.94% |
| 2019 | $92.11B | $104.21B | +$12.11B | +13.15% | +13.15% |
| 2018 | $90.04B | $92.11B | +$2.07B | +2.29% | +2.29% |
| 2017 | $84.98B | $90.04B | +$5.06B | +5.96% | +5.96% |
| 2016 | $79.24B | $84.98B | +$5.74B | +7.24% | +7.24% |
| 2015 | $73.92B | $79.24B | +$5.32B | +7.19% | +7.19% |
| 2014 | $71.12B | $73.92B | +$2.80B | +3.94% | +3.94% |
| 2013 | $61.53B | $71.12B | +$9.59B | +15.58% | +15.58% |
| 2012 | $60.80B | $61.53B | +$731.00M | +1.20% | +1.20% |
| 2011 | $58.84B | $60.80B | +$1.96B | +3.34% | +3.34% |
| 2010 | $61.64B | $58.84B | $-2.80B | -4.55% | -4.55% |
| 2009 | $62.46B | $61.64B | $-814.70M | -1.30% | -1.30% |
| 2008 | $61.39B | $62.46B | +$1.06B | +1.73% | +1.73% |
| 2007 | $57.01B | $61.39B | +$4.38B | +7.69% | +7.69% |
| 2006 | $45.15B | $57.01B | +$11.86B | +26.26% | +26.26% |
| 2005 | $20.82B | $45.15B | +$24.33B | +116.91% | +116.91% |
| 2004 | $16.75B | $20.82B | +$4.06B | +24.26% | +24.26% |
| 2003 | $13.26B | $16.75B | +$3.50B | +26.38% | +26.38% |
| 2002 | $10.44B | $13.26B | +$2.81B | +26.91% | +26.91% |
| 2001 | $17.31B | $10.44B | $-6.87B | -39.68% | -39.68% |
| 2000 | $12.35B | $17.31B | +$4.96B | +40.19% | +40.19% |
| 1999 | $11.07B | $12.35B | +$1.28B | +11.55% | +11.55% |
Quarterly Revenue — QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q1 2026 | $50.18B | +0.9% | +2.6% |
| Q4 2025 | $49.75B | -1.9% | +9.5% |
| Q3 2025 | $50.71B | +1.9% | +12.3% |
| Q2 2025 | $49.78B | +1.8% | +14.0% |
| Q1 2025 | $48.89B | +7.6% | +14.8% |
| Q4 2024 | $45.44B | +0.7% | +6.6% |
| Q3 2024 | $45.15B | +3.4% | +5.4% |
| Q2 2024 | $43.65B | +2.5% | -0.1% |
| Q1 2024 | $42.58B | -0.2% | +1.0% |
| Q4 2023 | $42.65B | -0.5% | +6.8% |
| Q3 2023 | $42.85B | -1.9% | +7.3% |
| Q2 2023 | $43.67B | +3.6% | +13.0% |
| Q1 2023 | $42.17B | +5.6% | +10.7% |
| Q4 2022 | $39.93B | -0.0% | +9.2% |
| Q3 2022 | $39.94B | +3.4% | +11.5% |
| Q2 2022 | $38.63B | +1.4% | +14.1% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About Elevance Health Inc.
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- Gail Koziara Boudreaux